Reports suggest that CDKN2A loss ranges in frequency from 6-20% in pLGG, with significant enrichment in pleomorphic xanthoastrocytoma [17, 51, 84, 190]. This evidence concerns the gene CDKN2A and pleomorphic xanthoastrocytoma.